Lsv Asset Management reports 2.34% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Lsv Asset Management
Latest Disclosed Ownership	8,855,362 shares
Latest Disclosed Value	$ 537,078

On May 11, 2026 - Lsv Asset Management filed a 13F-HR form disclosing ownership of 8,855,362 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $464,198,076 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 8,652,789 shares of Bristol-Myers Squibb Company. This represents a change in shares of 2.34% during the quarter. The current value of the position is $420,009,820 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-11	2026-03-31	13F	Bristol-Myers Squibb	COM	110122108	8,855,362	202,573	2.34	537	15.24	1.1574
2026-02-06	2025-12-31	13F	Bristol-Myers Squibb	COM	110122108	8,652,789	383,317	4.64	467	25.27	1.0178
2025-11-06	2025-09-30	13F	Bristol-Myers Squibb	COM	110122108	8,269,472	138,119	1.70	373	-1.06	0.8235
2025-08-11	2025-06-30	13F	Bristol-Myers Squibb	COM	110122108	8,131,353	14,880	0.18	376	-24.04	0.8811
2025-05-09	2025-03-31	13F	Bristol-Myers Squibb	COM	110122108	8,116,473	-202,745	-2.44	495	5.32	1.1881
2025-02-13	2024-12-31	13F	Bristol-Myers Squibb	COM	110122108	8,319,218	-226,073	-2.65	471	6.33	1.0861
2024-11-12	2024-09-30	13F	Bristol-Myers Squibb	COM	110122108	8,545,291	264,386	3.19	442	28.86	0.9476
2024-08-06	2024-06-30	13F	Bristol-Myers Squibb	COM	110122108	8,280,905	-251,336	-2.95	344	-25.76	0.7535
2024-05-06	2024-03-31	13F	Bristol-Myers Squibb	COM	110122108	8,532,241	-203,222	-2.33	463	3.13	0.9574
2024-02-06	2023-12-31	13F	Bristol-Myers Squibb	COM	110122108	8,735,463	-261,300	-2.90	448	-14.18	0.9781
2023-11-03	2023-09-30	13F	Bristol-Myers Squibb	COM	110122108	8,996,763	-401,892	-4.28	522	-13.14	1.2147
2023-08-02	2023-06-30	13F	Bristol-Myers Squibb	COM	110122108	9,398,655	-2,781	-0.03	601	-7.68	1.3252
2023-05-02	2023-03-31	13F	Bristol-Myers Squibb	COM	110122108	9,401,436	-43,401	-0.46	652	-4.12	1.4615
2023-02-08	2022-12-31	13F	Bristol-Myers Squibb	COM	110122108	9,444,837	-474,618	-4.78	680	-99.90	1.4986
2022-11-07	2022-09-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	9,919,455	-56,798	-0.57	705,174	-8.20	1.6567
2022-11-04	2022-09-30	13F	Bristol-Myers Squibb	COM	110122108	9,976,253	0		768,171		1.6610
2022-08-10	2022-06-30	13F	Bristol-Myers Squibb	COM	110122108	9,976,253	-260,793	-2.55	768,171	2.75	1.6610
2022-05-12	2022-03-31	13F	Bristol-Myers Squibb	COM	110122108	10,237,046	76,197	0.75	747,611	18.01	1.3723
2022-01-28	2021-12-31	13F	Bristol-Myers Squibb	COM	110122108	10,160,849	-312,640	-2.99	633,529	2.23	1.1220
2021-11-04	2021-09-30	13F	Bristol-Myers Squibb	COM	110122108	10,473,489	-171,154	-1.61	619,716	-12.87	1.1203
2021-08-04	2021-06-30	13F	Bristol-Myers Squibb	COM	110122108	10,644,643	89,320	0.85	711,275	6.74	1.2094
2021-04-30	2021-03-31	13F	Bristol-Myers Squibb	COM	110122108	10,555,323	-544,265	-4.90	666,357	-3.22	1.1383
2021-02-08	2020-12-31	13F	Bristol-Myers Squibb	COM	110122108	11,099,588	-477,214	-4.12	688,507	-1.36	1.2513
2020-10-23	2020-09-30	13F	Bristol-Myers Squibb	COM	110122108	11,576,802	253,311	2.24	697,965	4.83	1.4278
2020-08-05	2020-06-30	13F	Bristol-Myers Squibb	COM	110122108	11,323,491	1,553,690	15.90	665,821	22.27	1.3804
2020-05-07	2020-03-31	13F	Bristol-Myers Squibb	COM	110122108	9,769,801	30,757	0.32	544,568	-12.89	1.3158
2020-02-10	2019-12-31	13F	Bristol-Myers Squibb	COM	110122108	9,739,044	5,908,344	154.24	625,149	221.82	0.9743
2019-11-07	2019-09-30	13F	Bristol-Myers Squibb	COM	110122108	3,830,700	3,662,100	2,172.06	194,254	2,440.60	0.3212
2019-08-08	2019-06-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	168,600	0	0.00	7,646	-4.94	0.0123
2019-08-07	2019-06-30	13F	Bristol-Myers Squibb	COM	110122108	168,600	0		8,043
2019-05-07	2019-03-31	13F	Bristol-Myers Squibb	COM	110122108	168,600	0	0.00	8,043	-8.22	0.0129
2019-02-05	2018-12-31	13F	Bristol-Myers Squibb	COM	110122108	168,600	131,469	354.07	8,763	280.17	0.0156
2018-11-06	2018-09-30	13F	Bristol-Myers Squibb	COM	110122108	37,131	28,231	317.20	2,305	368.50	0.0034
2018-08-08	2018-06-30	13F	Bristol-Myers Squibb	COM	110122108	8,900	8,900		492		0.0008
2018-01-31	2017-12-31	13F	Bristol-Myers Squibb	COM	110122108	0	-8,000	-100.00	0	-100.00
2017-11-13	2017-09-30	13F	Bristol-Myers Squibb	COM	110122108	8,000	8,000	64.27	509	126.22	0.0008
2014-02-05	2013-12-31	13F	Bristol-Myers Squibb	COM	110122108	0	-4,870	-100.00	0	-100.00
2013-11-08	2013-09-30	13F	Bristol-Myers Squibb	COM	110122108	4,870	4,870		225		0.0006

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.